ONCS - OncoSec Medical Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
21.85M
Enterprise Value 3
6.92M
Trailing P/E
N/A
Forward P/E 1
-1.10
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
1.42
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-0.22

Trading Information

Stock Price History

Beta (5Y Monthly) 2.19
52-Week Change 3-69.71%
S&P500 52-Week Change 326.13%
52 Week High 39.5000
52 Week Low 31.6000
50-Day Moving Average 31.9909
200-Day Moving Average 32.0712

Share Statistics

Avg Vol (3 month) 384.69k
Avg Vol (10 day) 385.85k
Shares Outstanding 510.71M
Float 7.47M
% Held by Insiders 116.23%
% Held by Institutions 121.19%
Shares Short (Dec 30, 2019) 4280k
Short Ratio (Dec 30, 2019) 42.23
Short % of Float (Dec 30, 2019) 43.12%
Short % of Shares Outstanding (Dec 30, 2019) 42.61%
Shares Short (prior month Nov 28, 2019) 4324k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3May 20, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2019
Most Recent Quarter (mrq)Oct 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-72.96%
Return on Equity (ttm)-160.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -32.11M
Net Income Avi to Common (ttm)-32.46M
Diluted EPS (ttm)-3.8940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.95M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)1.81M
Total Debt/Equity (mrq)11.80
Current Ratio (mrq)2.79
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-30.36M
Levered Free Cash Flow (ttm)-17.54M